Study Stopped
Due to Covid-19 pandemic
Elite Athletes With Chronic Ankle Instability Using Spraino®: A Cohort Study
Fear of Re-injury and Ankle Function in Elite Athletes With Chronic Ankle Instability Using the Spraino® Shoe Patch: A Cohort Study
1 other identifier
interventional
N/A
1 country
2
Brief Summary
Fear of re-injury and deficiencies in ankle joint function are common conditions amongst high performance (elite) athletes with chronic ankle instability (CAI), who participate in indoor sports. This fear of re-injury associates with the high recurrence rate of lateral ankle sprains, which is a primary characteristic feature of CAI. The Spraino® shoe patch is a new Danish invention, which is designed to reduce the risk of sustaining lateral ankle sprains in this population. This cohort study will investigate self-reported fear of re-injury and objectively measured ankle joint function in elite indoor sports athletes with CAI, both before and after a 10-week period during which they will use Spraino® during all training sessions and games.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started May 2021
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 11, 2018
CompletedFirst Posted
Study publicly available on registry
October 16, 2018
CompletedStudy Start
First participant enrolled
May 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2021
CompletedMay 23, 2022
May 1, 2022
4 months
October 11, 2018
May 16, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Fear of re-injury (Continuous)
Fear of re-injury will be measured using a Numeric Rating Scale (NRS) from 0 to 100 with 10-point increments (e.g. by asking the participants: "How fearful are you of re-injuring your ankle?"), with lower scores indicating more fear of re-injury.
10 weeks
Secondary Outcomes (7)
Y-balance test (Continuous)
10 weeks
The side-hop test (fastest time). (Continuous)
10 weeks
The Foot and Ankle Ability Measure (FAAM) sports scale
10 weeks
Tampa Scale of Kinesiophobia-11 (TSK-11)
10 weeks
Fear-Avoidance Beliefs Questionnaire (FABQ)
10 weeks
- +2 more secondary outcomes
Other Outcomes (1)
Registration of adverse effects
10 weeks
Study Arms (1)
Spraino intervention group
EXPERIMENTALParticipants will use Spraino® as a measure to prevent future lateral ankle sprains during all training sessions and games.
Interventions
Spraino® is an adhesive polytetrafluoroethylene (PTFE or "Teflon") patch developed with the purpose of minimizing lateral shoe-surface friction whenever initial contact is carried out in an inverted position of the ankle joint. Each Spraino® PTFE patch has a minimum durability of 20 hours use and will be provided by the study sponsor, Spraino® ApS. The participants will receive four pairs of Spraino® upon their enrollment to the study.
Eligibility Criteria
You may qualify if:
- Participant is ≥ 18 years old at commencement of study.
- Participant can read, speak and understand English.
- Participant is playing in one of the two highest leagues in the following indoor sports: handball, volleyball and badminton with at least 32 training sessions during the study period.
- Participant is diagnosed with CAI using the definition endorsed by the International Ankle Consortium.:
- Participant has previously incurred at least one significant lateral ankle sprain that resulted in swelling, pain, and temporary loss of function at least 12 months prior to study enrollment.
- Participant has a history of multiple episodes of the ankle ''giving-way'', and/or recurrent sprain and/or "feelings of instability" in the past six months
- Participant has a Cumberland Ankle Instability Tool (CAIT) score \<24
- Participant can fully participate in training sessions and is eligible for game selection before enrollment in the study.
- Participant can receive and reply to text messages on a cell phone using Short Message Services (SMS).
You may not qualify if:
- History of medial ankle sprain
- History of ankle surgery
- Participant who does not agree to sign the informed consent to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Southern Denmarklead
- Copenhagen University Hospital, Hvidovrecollaborator
- Aalborg Universitycollaborator
- Metropolitan University Collegecollaborator
- Sprainocollaborator
Study Sites (2)
Physical Medicine and Rehabilitation Research-Copenhagen (PMR-C), Clinical Research Centre, Amager-Hvidovre Hospital, Copenhagen University
Hvidovre, 2650, Denmark
Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark
Odense, 5230, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Behnam Liaghat, MSc
Department of Sports Science & Clinical Biomechanics, University of Southern Denmark, Odense, Denmark
- STUDY DIRECTOR
Kristian Thorborg, PhD
Physical Medicine and Rehabilitation Research-Copenhagen (PMR-C), Clinical Research Centre, Amager-Hvidovre Hospital, Copenhagen University, Hvidovre, Denmark
- STUDY CHAIR
Thomas Q Bandholm, PhD
Physical Medicine and Rehabilitation Research-Copenhagen (PMR-C), Clinical Research Centre, Amager-Hvidovre Hospital, Copenhagen University, Hvidovre, Denmark
- STUDY CHAIR
Eamonn Delahunt, PhD
School of Public Health, Physiotherapy and Sports Science, University College Dublin, Dublin, Ireland
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 11, 2018
First Posted
October 16, 2018
Study Start
May 1, 2021
Primary Completion
September 1, 2021
Study Completion
September 1, 2021
Last Updated
May 23, 2022
Record last verified: 2022-05